Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ:TLRY)

6.890 +0.140 (+2.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Marijuana Rescheduling Has Arrived. Don't Make This Mistake ↗
The Trump administration recently rescheduled medical marijuana from a Schedule I to Schedule III substance. 
Via The Motley Fool
Topics Cannabis Government
News headline image
This Trump Policy Shift Could Be a Game Changer for Cannabis Stocks: 2 Stocks to Watch Now
A federal shift toward Schedule 3 may boost cannabis stocks, even as recreational use remains restricted. 
Via Barchart.com
Topics Cannabis Government Law Enforcement
News headline image
Is Tilray a Textbook Example of a Value Trap? ↗
Tilray doesn't fit squarely into the value trap or value stock categories. 
Via The Motley Fool
Topics Cannabis
News headline image
The Cannabis Sector's Billion-Dollar Tax Cut ↗
Via MarketBeat
Topics Cannabis
News headline image
Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling
Tilray Medical Poised to Accelerate U.S. Medical Cannabis Access for Patients 
From Tilray Brands, Inc.
Via GlobeNewswire
News headline image
BrewDog USA Doubles Down on Headliners and Ignites Next Wave of Innovation for Spring and Summer
From Tilray Brands, Inc.
Via GlobeNewswire
420 with CNW — CNN Documentary Explores How Medical Marijuana is Helping Women
Via Investor Brand Network
Topics Cannabis
420 with CNW — CNN Documentary Explores How Medical Marijuana is Helping Women
Via CannabisNewsWire
Topics Cannabis
News headline image
Tilray Stock Jumps As Trump Administration Eyes Marijuana Reclassification: Report ↗
Shares of Tilray Brands (NASDAQ: TLRY) are trading higher Wednesday afternoon following breaking news of a potential major regulatory shift. 
Via Benzinga
Topics Cannabis Government
News headline image
1 Wall Street Analyst Says Tilray Stock Could Jump Over 40%. Should You Believe It? ↗
Tilray is showing signs of improvement. But a 40% jump over the next 12 months might be a stretch. 
Via The Motley Fool
Topics Cannabis
News headline image
Here's What to Expect From Air Products and Chemicals' Next Earnings Report
Air Products and Chemicals is expected to release its fiscal second-quarter earnings this month, and analysts project a double-digit earnings growth. 
Via Barchart.com
Topics Cannabis ETFs
News headline image
Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher through mid-September. 
Via Barchart.com
Topics Cannabis Government
News headline image
Apple's Q2 2026 Earnings: What to Expect
Apple is expected to announce its second-quarter results this month, and analysts are projecting a double-digit rise in its EPS 
Via Barchart.com
Topics Cannabis ETFs
News headline image
The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market ↗
The cannabis stock has lost around 96% of its value over the past five years. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Brands Marks 4/20, Reaffirming Its Leadership in Cannabis and Commitment to Advancing Medical Care
From Tilray Brands, Inc.
Via GlobeNewswire
News headline image
Why Is Tilray Brands Stock Falling Wednesday? ↗
Tilray (TLRY) shares dip on a $180M equity program. Explore its global push into U.K. healthcare, BrewDog growth, and U.S. market strategy. 
Via Benzinga
News headline image
Tilray Brands Accelerates Next Phase of Global Growth and Market Leadership
Tilray Advances UK Healthcare Platform with Lyphe Acquisition, Positions BrewDog for Strong Growth, and Prepares for U.S. Rescheduling and Medical Cannabis Opportunity 
From Tilray Brands, Inc.
Via GlobeNewswire
News headline image
Tilray Posted Record Numbers Last Quarter, but Where the Bulk of Its Growth Has Come From Over the Past 4 Years Might Surprise You ↗
Tilray has leaned on acquisitions heavily over the past few years in order to grow its business. 
Via The Motley Fool
Topics Cannabis
420 with CNW — Advisory Council Recommends Marijuana Legalization in North Carolina
Via Investor Brand Network
Topics Cannabis
420 with CNW — Advisory Council Recommends Marijuana Legalization in North Carolina
Via CannabisNewsWire
Topics Cannabis
News headline image
Why Tilray Stock Got Hammered in March ↗
What's another month of struggle for a company in the cannabis industry? 
Via The Motley Fool
Topics Cannabis
News headline image
What's Going On With Tilray Brands Stock On Wednesday? ↗
Tilray shares gained after launching a high-potency cannabis brand, with innovation and strong momentum outweighing mixed technical signals. 
Via Benzinga
Topics Cannabis
News headline image
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts
First Released in 2025 as the limited-edition Broncos Whiskey, Breckenridge Honey Whiskey Delivers Distinctive Character and Exceptional Flavor 
From Tilray Brands, Inc.
Via GlobeNewswire
News headline image
Why Tilray Brands Investors Shouldn't Expect the Company to Post a Profit Anytime Soon ↗
The company's loss shrank drastically last quarter, but that was largely because it didn't incur significant impairment charges. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Brands Reports Record Q3 2026 Results: A Deep Dive into the $207 Million Revenue Milestone
Tilray Brands (NASDAQ:TLRY) has officially transitioned from a volatile cannabis producer to a diversified global consumer packaged goods (CPG) powerhouse, reporting record-breaking Q3 fiscal 2026... 
Via MarketMinute
Topics Cannabis Earnings Economy
News headline image
Forget Tilray: This Boring Dividend Beast Is a Much Savvier Play ↗
And it's in a cannabis-adjacent sector. 
Via The Motley Fool
Topics Cannabis
News headline image
Tilray Brands Surges on Record $207 Million Q3 Revenue: Margin Recovery in Beverages and German Cannabis Growth Signal Turnaround
NEW YORK — Tilray Brands, Inc. (NASDAQ:TLRY) delivered a resounding message to the market this week, reporting a record-breaking $206.7 million in net revenue for its fiscal 2026 third quarter. The... 
Via MarketMinute
Topics Cannabis Earnings Economy
News headline image
Tilray Stock Continues To Climb After Earnings Beat, Record Revenue ↗
Tilray Brands shares are trading higher Thursday afternoon after the company's fiscal Q3 results topped Wall Street expectations. 
Via Benzinga
Topics Earnings
News headline image
Tilray Surges on Record Revenue and Global Expansion Despite Third-Quarter Earnings Miss
In a paradoxical display of market confidence, shares of Tilray Brands (NASDAQ:TLRY) surged over 8% on Wednesday following the release of its fiscal third-quarter 2026 financial results. While the... 
Via MarketMinute
Topics Cannabis Earnings
News headline image
Tilray Brands Reaffirms Outlook After Record Quarter ↗
Tilray (TLRY) shares jump in premarket after record Q3 results. Adjusted EPS of $0.02 beats estimates as revenue hits a record $206.7M. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.